US Patent 7959916 Negative immunomodulation of immune responses by ERp5
Patent 7959916 was granted and assigned to Fred Hutchinson Cancer Research Center on June, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+280 characters)
Article
Patent abstract
The present invention relates to methods of treating immune disorders and cancers. In particular the invention provides methods of inhibiting the negative immunomodulatory effects of ERp-5 on T cells and dendritic cells, in conjunction with other surface receptors.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Thomas Spies0
Veronika Groh-Spies0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07959916 Negative immunomodulation of immune responses by ERp5 US Patent 7959916 Negative immunomodulation of immune responses by ERp5
Infobox
Patent Number
079599160
Patent Number
79599160
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079599160
Date of Patent
June 14, 2011
0Patent Application Number
121080690
Date Filed
April 23, 2008
0Patent Primary Examiner
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07959916 Negative immunomodulation of immune responses by ERp5
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07959916
Date of patent
June 14, 2011
Patent application number
12108069
Date Filed
April 23, 2008
Patent primary examiner
Find more entities like US Patent 7959916 Negative immunomodulation of immune responses by ERp5
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.